Company Overview and News

Add 4508
to your dashboard

Headline News

Akebia Therapeutics Is A Buy With The Recent Stock Price Pullback

2017-11-10 seekingalpha
This was written for our subscribers last week, and since then the stock is down 15% on EPS loss. (19-0)

VIVUS Reports Third Quarter 2017 Financial Results

2017-11-07 marketwired
CAMPBELL, CA--(Marketwired - November 07, 2017) - VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a biopharmaceutical company committed to the development and commercialization of innovative therapies focusing on treatments for patients with serious unmet medical needs, today reported financial results for the quarter ended September 30, 2017 and provided a business update. (11-0)

Qumu's (QUMU) CEO Vernon Hanzlik on Q3 2017 Results - Earnings Call Transcript

2017-11-01 seekingalpha
Good day, ladies and gentlemen, and welcome to the Qumu Third Quarter 2017 Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] (6-0)